Dexcom

Dexcom U, our premier Name, Image, and Likeness program for college athletes living with diabetes, is back for an expanded fourth season, featuring the first-ever nationwide open call for passionate and inspiring college athletes to join its roster. We are looking for college athletes with diabetes who are passionate about sharing their inspirational stories with others to serve as role models for the next generation of youth athletes. Have someone in mind? From now through May 23, we’re accepting nominations from athletes, coaches, friends, and family members through an online submission. To learn more about Dexcom U or to nominate a college athlete for the 2025 roster, visit https://lnkd.in/g9S_sCCK. #DexcomU

The FDA has officially cleared the Dexcom G7 15 Day Continuous Glucose Monitoring (CGM) System for people ages 18 and above with diabetes in the U.S. Listening to the needs of our users, we developed the longest lasting*1 and most accurate CGM system, empowering people to take control of health with our best-in-class technology. 𝗡𝗲𝘄 𝘄𝗶𝘁𝗵 𝗗𝗲𝘅𝗰𝗼𝗺 𝗚𝟳 𝟭𝟱 𝗗𝗮𝘆:    • Longest lasting CGM system with 15.5 days of wear*1  • Best-in-class accuracy with an overall MARD of 8.0%†    • Easier glucose management with fewer monthly sensors and reduced monthly waste. You can read more about G7 15 Day here: https://lnkd.in/g_-_nW9A. #Dexcom #DexcomG7 *Excludes implantable CGM systems 1 A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per the package labeling, approximately 26% of sensors may not last for the full 15 days. † Garg SK, et al. Diabetes Technol Ther. 2025. doi: 10.1089/dia.2025.0139. Epub ahead of print.

Find out why our culture at Dexcom is thriving as seen through the lens of Kayla Ramos, Senior Technical Program Manager and Co-President of the Dexcom Asian & Pacific Islander (DAPI) ERG.

We're excited to extend a warm welcome to Jon Coleman as he joins Dexcom as our new Chief Commercial Officer. His impressive track record and strong performance across a variety of healthcare sectors and channels will fuel our continued growth and unwavering commitment to delivering exceptional experiences - empowering all people to take control of their health. Welcome, Jon! Learn more here https://lnkd.in/gKm7pfcX

We’re proud to announce the expansion of the Dexcom G7 and Omnipod® 5 partnership to Australia and the Netherlands, with Belgium, Canada and Switzerland coming soon! After a successful US launch in 2024, we’re excited to bring AID connected solutions to even more people living with diabetes. Dexcom is the only CGM brand that supports data sharing with the Follow App when connected to Omnipod® 5* (1), offering greater confidence and peace of mind to its users, their loved ones, and caregivers (2). This expansion underscores our commitment to delivering the best connectivity experience for our community to continue driving meaningful outcomes. Learn more at https://lnkd.in/g6vtzWvH *Separate Dexcom Follow app and internet connection required 1) Dexcom G7 User Guide, Freestyle Libre User Guides, and Omnipod 5 User Guide 2) Polonsky WH, et al. Diabetes Technol Ther. 2021;23(3):195-202

Did you know that more than 50% of healthcare practitioners across Europe and the Middle East believe that better access to CGM would most positively help their patients manage diabetes over the next 10 years? In fact, they say CGM is more crucial to Type 2 treatment than medications. Today, we released a new, first-of-its-kind report just in time for #ATTD2025 including findings like this from people with Type 2 diabetes and their healthcare practitioners across the EMEA region. The comprehensive report looks at the importance of innovative technology to help the millions of people living with Type 2 diabetes manage their condition. Check out the full report and other exciting updates planned for this year’s conference here: https://lnkd.in/gZ9S2hzy

Navigating a chronic disease can be challenging, but in the age of misinformation, it has become even more difficult to avoid stereotypes and access credible information. At #SXSW #DexcomWarrior Lance Bass joined Joe Nadglowski with Obesity Action Coalition to share their personal experiences navigating chronic diseases and the stereotypes that surround them. Moderated by Dr. Geeta Nayyar, MD, MBA, the panel explored the power of authentic patient storytelling and supportive communities to help combat these myths, and how tools like Dexcom G7 empowers people to take control of health, helping alleviate the daily burden of living with a chronic disease. You can read more about the panel’s takeaways by checking out Lance’s interview with The Austin American-Statesman: https://lnkd.in/gz6YfMnJ

Our ATTD 2025 schedule is jam packed with canʼt miss moments. Swipe to see details on symposiums highlighting revolutions in diabetes care, educational in-booth sessions, and more. Get all the details on how to attend here: https://lnkd.in/geKFPkyw #DexcomCGM #ATTD2025

This International Women’s Day, Dexcom proudly honors the women who have shaped our journey and the many who are guiding us toward a brighter future.   This occasion allows us to celebrate the female leaders, mentors, and change-makers making a real difference across the globe. From our dedicated employees at Dexcom to our network of Warriors and caretakers, each of you is contributing to the future of diabetes care. We invite our entire Dexcom community to take a moment to recognize the women in your lives who inspire and empower you this International Women’s Day. #IWD2025

Who’s heading to Austin for #SXSW 2025? #DexcomWarrior Lance Bass is joining Joe Nadglowski for a meaningful conversation moderated by Dr. Geeta Nayyar, MD, MBA on how to identify and combat harmful myths and misinformation about chronic diseases. The session will dive into the realities of living with a chronic condition, which impacts nearly half of the US population, and how you can use tools like Dexcom glucose biosensors to help take control of your health. If you’re attending, join us on Tuesday, March 11 from 4 – 5pm CT at the JW Marriott! #SXSW